OYST
Oyster Point Pharma, Inc. Common Stock
OYST
OYST
Delisted
OYST was delisted on the 30th of December, 2022.
60 hedge funds and large institutions have $331M invested in Oyster Point Pharma, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 28 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
-6
Holders Change %
-9.09%
% of All Funds
1.06%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
5
Increased
28
Reduced
12
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.4M |
| 2 |
First Manhattan
New York
|
+$1.31M |
| 3 |
Creative Planning
Overland Park,
Kansas
|
+$1.3M |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$1.28M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$700K |
Top Sellers
| 1 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$4.19M |
| 2 |
SCM
Sio Capital Management
New York
|
-$2.23M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.48M |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$1.09M |
| 5 |
Millennium Management
New York
|
-$1.06M |
